Top 9 Foresite Capital Management V Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ALMS | ALUMIS INC. | 47.94% | 5.90M | $129.9M | +2.04%(+117.65K) | $13.22(+73.01%) | 2026-03-31 | |
| CGON | CG Oncology, Inc. | 25.08% | 1.00M | $68.0M | +0.00%(+0) | $38.47(+73.96%) | 2026-03-31 | |
| IRON | Disc Medicine, Inc. | 8.83% | 374.1K | $23.9M | +25.08%(+75.00K) | $44.83(+49.14%) | 2026-03-31 | |
| HIMS | Hims & Hers Health, Inc. | 5.65% | 738.2K | $15.3M | +170.24%(+465.00K) | $19.74(+26.87%) | 2026-03-31 | |
| EIKN | Eikon Therapeutics, Inc. | 5.15% | 1.32M | $14.0M | new | $10.58(+25.24%) | 2026-03-31 | |
| LYEL | Lyell Immunopharma, Inc. | 3.53% | 477.1K | $9.6M | +0.00%(+0) | $19.07(-6.03%) | 2026-03-31 | |
| PHVS | Pharvaris N.V. | 2.02% | 194.1K | $5.5M | new | $28.00(+8.57%) | 2026-03-31 | |
| NRIX | Nurix Therapeutics, Inc. | 1.52% | 265.0K | $4.1M | new | $17.23(-8.01%) | 2026-03-31 | |
| MAZE | Maze Therapeutics, Inc. | 0.29% | 25.9K | $773K | -69.98%(-60.39K) | $11.01(+132.15%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +44.55% | +202.04% |
| Top 20 Holdings Unweighted | +35.49% | +148.71% |
Sign up free to track Foresite Capital Management V Llc, compare funds side by side, and get alerts the moment positions change.